Cervomed to present at h.c. wainwright 25th annual global investment conference

Boston , sept. 5, 2023 /prnewswire/ -- cervomed inc. (nasdaq: crvo), a clinical-stage company focused on developing treatments for degenerative diseases of the brain, today announced that the company's senior management team will present at the h.c.
CRVO Ratings Summary
CRVO Quant Ranking